J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study
Ignacio Marín-Jiménez,Pilar Nos,Eugeni Domènech,Sabino Riestra,Javier P. Gisbert,Xavier Calvet,Xavier Cortés,Eva Iglesias,José María Huguet,Carlos Taxonera,Ramón Tena Fernández,Daniel Carpio,Ana Gutiérrez,Jordi Guardiola,Luisa Castro Laria,Beatriz Sicilia,Luis Bujanda,Luis Cea-Calvo,Cristina Romero,Óscar Nogales Rincón,Berta Juliá,Julián Panés +21 more
TL;DR: In patients with UC, SCCAI self-administration via an online tool resulted in a high percentage of agreement with evaluation by gastroenterologists, with a remarkably high negative predictive value for disease activity.
Journal ArticleDOI
Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference.
TL;DR: The results of the 2nd Spanish Consensus Conference for appropriate practice regarding indications for eradication, diagnostic tests, and therapy regimens for Helicobacter pylori infection are summarized.
Journal ArticleDOI
Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients.
Inés D. Pousa,J. Maté,Xamila Salcedo-Mora,Maria T. Abreu,Ricardo Moreno-Otero,Javier P. Gisbert +5 more
TL;DR: In comparison with healthy controls, CD patients were found to have an active angiogenic profile, as detected by significant alterations in levels of angiogenesis soluble markers.
Journal ArticleDOI
Actualización de la eficacia de la terapia triple para la infección por Helicobacter pylori y de la resistencia a claritromicina en España (2007-2012)
TL;DR: La eficacia de the terapia triple parece suboptima en los estudios espanoles mas recientes, debido probablemente a tasas de resistencia a claritromicina superiores a las previamente descritas.
Journal ArticleDOI
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection.
Ignasi Puig,Ignasi Puig,Sheila López-Góngora,Xavier Calvet,Albert Villoria,Mireia Baylina,Jordi Sánchez-Delgado,David L. Suarez,Victor Garcia-Hernando,Javier P. Gisbert +9 more
TL;DR: The evidence in favor of SGT as rescue therapy is currently insufficient to recommend its use, but SGT may be an acceptable option as rescue treatment.